Market
Stoke Therapeutics Inc [STOK] is 95.63% higher this YTD. Is it still time to buy?
Stoke Therapeutics Inc [NASDAQ: STOK] traded at a high on Tuesday, posting a 58.31 gain after which it closed the day’ session at $10.29. The company report on March 26, 2024 at 4:07 PM that Stoke Therapeutics Announces Proposed Public Offering. Stoke Therapeutics, Inc. (Nasdaq:
